Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in EuropeHealthcare & Pharmaceuticals · 11:01 AM UTC
At the height of Europe's vaccine supply crisis in March, Johnson & Johnson's (J&J) single-dose COVID-19 vaccine was touted as a game-changer. But two months into its rollout, the shot has the lowest uptake of all four approved vaccines.
Asia PacificHong Kong pro-democracy tabloid Apple Daily to print final edition on Thursday
United StatesBiden plans new steps to combat U.S. gun violence as violent crime climbs
EnergyU.S. solar developers see opportunity in America's post-industrial lands
Healthcare & PharmaceuticalsU.S. panel to review heart inflammation cases after Pfizer, Moderna vaccines
United StatesU.S. Democrats vow 'long march' toward voting rights reforms
EuropeEuro zone business growth at 15-year high as demand unleashed -PMI
Asia Pacific · 6:03 AM UTCEXCLUSIVE Harvard wasn't pressured over Toshiba, former Japan adviser says
A former Japanese government adviser said he did not put pressure on Harvard University's endowment fund to influence its voting at Toshiba Corp's (6502.T) contested shareholder meeting last year, and that the fund should "set the record straight".
Sustainable Business · 8:04 AM UTCAnalysis: Greener oil or green industry? Gridlock puts Norway in a bind
Norway's oil and gas industry is counting on renewable power from hydro plants to cut emissions from its offshore platforms but rival demand from the green economy is putting a spanner in the works.